These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 30897496)
1. Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease. Rawat R; Starczynowski DT; Ntziachristos P Curr Opin Cell Biol; 2019 Jun; 58():85-94. PubMed ID: 30897496 [TBL] [Abstract][Full Text] [Related]
2. Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects. Yeasmin Khusbu F; Chen FZ; Chen HC Cell Biochem Funct; 2018 Jul; 36(5):244-254. PubMed ID: 29781103 [TBL] [Abstract][Full Text] [Related]
3. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors. Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217 [TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity. Han Y; Yun CC FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475 [TBL] [Abstract][Full Text] [Related]
5. Current and future directions of USP7 interactome in cancer study. Park HB; Baek KH Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071 [TBL] [Abstract][Full Text] [Related]
6. Dissenting degradation: Deubiquitinases in cell cycle and cancer. Bonacci T; Emanuele MJ Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment. Carreira LD; Oliveira RI; Moreira VM; Salvador JAR Expert Opin Ther Targets; 2023; 27(11):1043-1058. PubMed ID: 37789645 [TBL] [Abstract][Full Text] [Related]
8. USP7: Target Validation and Drug Discovery for Cancer Therapy. Zhou J; Wang J; Chen C; Yuan H; Wen X; Sun H Med Chem; 2018; 14(1):3-18. PubMed ID: 29065837 [TBL] [Abstract][Full Text] [Related]
9. USP7 small-molecule inhibitors interfere with ubiquitin binding. Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385 [TBL] [Abstract][Full Text] [Related]
10. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling. Cai J; Chen HY; Peng SJ; Meng JL; Wang Y; Zhou Y; Qian XP; Sun XY; Pang XW; Zhang Y; Zhang J FASEB J; 2018 Oct; 32(10):5238-5249. PubMed ID: 29688809 [TBL] [Abstract][Full Text] [Related]
11. Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth. Li X; Kong L; Yang Q; Duan A; Ju X; Cai B; Chen L; An T; Li Y J Biol Chem; 2020 Mar; 295(11):3576-3589. PubMed ID: 32029476 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of UVSSA ubiquitination suppresses transcription-coupled nucleotide excision repair deficiency caused by dissociation from USP7. Higa M; Tanaka K; Saijo M FEBS J; 2018 Mar; 285(5):965-976. PubMed ID: 29323787 [TBL] [Abstract][Full Text] [Related]
14. A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification. Nicklas S; Hillje AL; Okawa S; Rudolph IM; Collmann FM; van Wuellen T; Del Sol A; Schwamborn JC Cell Death Differ; 2019 Mar; 26(4):728-740. PubMed ID: 29899379 [TBL] [Abstract][Full Text] [Related]
15. Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity. Rossio V; Paulo JA; Chick J; Brasher B; Gygi SP; King RW Cell Chem Biol; 2021 Apr; 28(4):487-502.e5. PubMed ID: 33417828 [TBL] [Abstract][Full Text] [Related]
16. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition. Moghadasi SA; Moraes SN; Harris RS J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708 [TBL] [Abstract][Full Text] [Related]
17. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms. Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420 [TBL] [Abstract][Full Text] [Related]
18. The equilibrium of tumor suppression: DUBs as active regulators of PTEN. Christine A; Park MK; Song SJ; Song MS Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557 [TBL] [Abstract][Full Text] [Related]
19. The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy. Nininahazwe L; Liu B; He C; Zhang H; Chen ZS Drug Discov Today; 2021 Feb; 26(2):490-502. PubMed ID: 33157193 [TBL] [Abstract][Full Text] [Related]
20. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits. Mitxitorena I; Somma D; Mitchell JP; Lepistö M; Tyrchan C; Smith EL; Kiely PA; Walden H; Keeshan K; Carmody RJ J Biol Chem; 2020 Aug; 295(33):11754-11763. PubMed ID: 32587091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]